BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 21632815)

  • 1. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
    Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
    Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome.
    Tan TM; Vanderpump M; Khoo B; Patterson M; Ghatei MA; Goldstone AP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4162-5. PubMed ID: 15292365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome.
    De Waele K; Ishkanian SL; Bogarin R; Miranda CA; Ghatei MA; Bloom SR; Pacaud D; Chanoine JP
    Eur J Endocrinol; 2008 Oct; 159(4):381-8. PubMed ID: 18603572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
    Goldstone AP; Holland AJ; Butler JV; Whittington JE
    Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
    Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
    Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response.
    Giménez-Palop O; Giménez-Pérez G; Mauricio D; González-Clemente JM; Potau N; Berlanga E; Trallero R; Laferrère B; Caixàs A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):198-204. PubMed ID: 17223988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of administration time of exenatide on satiety responses, blood glucose, and adverse events in healthy volunteers.
    Pinelli NR; Jantz A; Smith Z; Abouhassan A; Ayar C; Jaber NA; Clarke AW; Commissaris RL; Jaber LA
    J Clin Pharmacol; 2011 Feb; 51(2):165-72. PubMed ID: 20484613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpectedly increased anorexigenic postprandial responses of PYY and GLP-1 to fast ice cream consumption in adult patients with Prader-Willi syndrome.
    Rigamonti AE; Bini S; Grugni G; Agosti F; De Col A; Mallone M; Cella SG; Sartorio A
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):542-50. PubMed ID: 24372155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal response to the anorexic effect of GHS-R inhibitors and exenatide in male Snord116 deletion mouse model for Prader-Willi syndrome.
    Lin D; Wang Q; Ran H; Liu K; Wang Y; Wang J; Liu Y; Chen R; Sun Y; Liu R; Ding F
    Endocrinology; 2014 Jul; 155(7):2355-62. PubMed ID: 24735326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic/anorexigenic peptides.
    Rigamonti AE; Casnici C; Marelli O; De Col A; Tamini S; Lucchetti E; Tringali G; De Micheli R; Abbruzzese L; Bortolotti M; Cella SG; Sartorio A
    Nutr Res; 2018 Apr; 52():71-79. PubMed ID: 29530622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
    Allas S; Caixàs A; Poitou C; Coupaye M; Thuilleaux D; Lorenzini F; Diene G; Crinò A; Illouz F; Grugni G; Potvin D; Bocchini S; Delale T; Abribat T; Tauber M
    PLoS One; 2018; 13(1):e0190849. PubMed ID: 29320575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
    DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exercise on gut peptides, energy intake and appetite.
    Martins C; Morgan LM; Bloom SR; Robertson MD
    J Endocrinol; 2007 May; 193(2):251-8. PubMed ID: 17470516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY, cholecystokinin, insulin and ghrelin response to meal did not change, but mean serum levels of insulin is reduced in children with Prader-Willi syndrome.
    Paik KH; Jin DK; Lee KH; Armstrong L; Lee JE; Oh YJ; Kim S; Kwon EK; Choe YH
    J Korean Med Sci; 2007 Jun; 22(3):436-41. PubMed ID: 17596650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.
    Gumus Balikcioglu P; Balikcioglu M; Muehlbauer MJ; Purnell JQ; Broadhurst D; Freemark M; Haqq AM
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3822-31. PubMed ID: 26259133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome.
    Haqq AM; Stadler DD; Rosenfeld RG; Pratt KL; Weigle DS; Frayo RS; LaFranchi SH; Cummings DE; Purnell JQ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3573-6. PubMed ID: 12915638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.